261 related articles for article (PubMed ID: 16123076)
21. Expression of basic fibroblast growth factor (bFGF), FGF receptor 1 and FGF receptor 2 in uterine leiomyomas and myometrium during the menstrual cycle, after menopause and GnRHa treatment.
Wu X; Blanck A; Olovsson M; Möller B; Lindblom B
Acta Obstet Gynecol Scand; 2001 Jun; 80(6):497-504. PubMed ID: 11380284
[TBL] [Abstract][Full Text] [Related]
22. Locostatin, a disrupter of Raf kinase inhibitor protein, inhibits extracellular matrix production, proliferation, and migration in human uterine leiomyoma and myometrial cells.
Janjusevic M; Greco S; Islam MS; Castellucci C; Ciavattini A; Toti P; Petraglia F; Ciarmela P
Fertil Steril; 2016 Nov; 106(6):1530-1538.e1. PubMed ID: 27565262
[TBL] [Abstract][Full Text] [Related]
23. Decreased expression of mac25 mRNA in uterine leiomyomata compared with adjacent myometrium.
Kim JG; Kim MH; Kim IS; Moon SY; Kang SB; Lee HP; Lee JY
Am J Reprod Immunol; 2000 Jan; 43(1):53-7. PubMed ID: 10698042
[TBL] [Abstract][Full Text] [Related]
24. Expression, menstrual cycle-dependent activation, and bimodal mitogenic effect of transforming growth factor-beta1 in human myometrium and leiomyoma.
Arici A; Sozen I
Am J Obstet Gynecol; 2003 Jan; 188(1):76-83. PubMed ID: 12548199
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of tumor necrosis factor-α on matrix metalloproteinase-2 expression in human myometrial and uterine leiomyoma smooth muscle cells.
Wang Y; Feng G; Wang J; Zhou Y; Liu Y; Shi Y; Zhu Y; Lin W; Xu Y; Li Z
Hum Reprod; 2015 Jan; 30(1):61-70. PubMed ID: 25398968
[TBL] [Abstract][Full Text] [Related]
26. Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pretreated women.
Vollenhoven BJ; Pearce P; Herington AC; Healy DL
Clin Endocrinol (Oxf); 1994 Apr; 40(4):537-44. PubMed ID: 8187322
[TBL] [Abstract][Full Text] [Related]
27. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta.
Lee BS; Nowak RA
J Clin Endocrinol Metab; 2001 Feb; 86(2):913-20. PubMed ID: 11158066
[TBL] [Abstract][Full Text] [Related]
28. Interleukin 8 production and interleukin 8 receptor expression in human myometrium and leiomyoma.
Senturk LM; Sozen I; Gutierrez L; Arici A
Am J Obstet Gynecol; 2001 Mar; 184(4):559-66. PubMed ID: 11262453
[TBL] [Abstract][Full Text] [Related]
29. Proteoglycans in Leiomyoma and Normal Myometrium: Abundance, Steroid Hormone Control, and Implications for Pathophysiology.
Barker NM; Carrino DA; Caplan AI; Hurd WW; Liu JH; Tan H; Mesiano S
Reprod Sci; 2016 Mar; 23(3):302-9. PubMed ID: 26423601
[TBL] [Abstract][Full Text] [Related]
30. Quantification of vascular endothelial growth factor-A in leiomyomas and adjacent myometrium.
Gentry CC; Okolo SO; Fong LF; Crow JC; Maclean AB; Perrett CW
Clin Sci (Lond); 2001 Dec; 101(6):691-5. PubMed ID: 11724658
[TBL] [Abstract][Full Text] [Related]
31. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
[TBL] [Abstract][Full Text] [Related]
32. Preoperative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-beta3 and connective tissue growth factor.
De Falco M; Staibano S; D'Armiento FP; Mascolo M; Salvatore G; Busiello A; Carbone IF; Pollio F; Di Lieto A
J Soc Gynecol Investig; 2006 May; 13(4):297-303. PubMed ID: 16697947
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth interacting factor expression in leiomyoma compared with myometrium.
Yen-Ping Ho J; Man WC; Wen Y; Polan ML; Shih-Chu Ho E; Chen B
Fertil Steril; 2010 Aug; 94(3):1078-83. PubMed ID: 19524896
[TBL] [Abstract][Full Text] [Related]
34. Expression of proliferative and preapoptotic molecules in human myometrium and leiomyoma throughout the menstrual cycle.
Kayisli UA; Berkkanoglu M; Kizilay G; Senturk L; Arici A
Reprod Sci; 2007 Oct; 14(7):678-86. PubMed ID: 18000229
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of latent TGF-beta binding protein-1 and fibrillin-1 in human uterine leiomyomata.
Zhao Y; Wen Y; Polan ML; Qiao J; Chen BH
Mol Hum Reprod; 2007 May; 13(5):343-9. PubMed ID: 17360930
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of caveolin-1 in human myometrial and uterine leiomyoma smooth muscle.
Zhou Y; Ren Y; Cui L; Li Z; Zhu Y; Lin W; Wang Y
Am J Obstet Gynecol; 2014 Nov; 211(5):496.e1-496.e13. PubMed ID: 24909339
[TBL] [Abstract][Full Text] [Related]
37. Differential effect of gonadotropin-releasing hormone analogue treatment on estrogen levels and sulfatase activity in uterine leiomyoma and myometrium.
van de Ven J; Donker TH; Blankenstein MA; Thijssen JH
Fertil Steril; 2002 Jun; 77(6):1227-32. PubMed ID: 12057733
[TBL] [Abstract][Full Text] [Related]
38. Oxytocin receptor and its messenger ribonucleic acid in human leiomyoma and myometrium.
Lee KH; Khan-Dawood FS; Dawood MY
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 1):620-7. PubMed ID: 9757961
[TBL] [Abstract][Full Text] [Related]
39. Fibromodulin-deficiency alters temporospatial expression patterns of transforming growth factor-β ligands and receptors during adult mouse skin wound healing.
Zheng Z; Lee KS; Zhang X; Nguyen C; Hsu C; Wang JZ; Rackohn TM; Enjamuri DR; Murphy M; Ting K; Soo C
PLoS One; 2014; 9(6):e90817. PubMed ID: 24603701
[TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor-β signaling pathway cross-talking with ERα signaling pathway on regulating the growth of uterine leiomyoma activated by phenolic environmental estrogens in vitro.
Shen Y; Wu Y; Lu Q; Zhang P; Ren M
Tumour Biol; 2016 Jan; 37(1):455-62. PubMed ID: 26224478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
